WA Showcases Innovation at AusBiotech 2025 – AusMedtech heads to Perth in 2026

Western Australia’s life sciences sector took centre stage at AusBiotech 2025 in Melbourne last month, where the Office of Medical Research and Innovation (OMRI) joined the WA delegation to promote the State’s growing strengths in medical research, biotechnology, and clinical innovation.

Representatives Adam James and Iain Hill from OMRI engaged with multinational companies, venture capital firms, early-stage innovators, and critical service providers, helping to raise WA’s profile as a hub for cutting-edge research and investment.

The WA delegation, supported by the Department of Health and the Department of Energy and Economic Diversification, showcased opportunities for collaboration and investment, reinforcing the State’s commitment to driving impact through partnerships and innovation.

Event highlights:

• Strong WA business presence and significant industry participation, including international delegates.
• Focus on translation support services, manufacturing, and consumables.
• Breakout sessions offered expert insights on innovation, problem-solving, and strategies to accelerate progress.
• Startup pitch sessions spotlighted emerging products, while reverse pitch sessions with CSL, Eli Lilly, and AbbVie revealed corporate approaches to research and partnership.

This year’s event demonstrated clear opportunities to showcase WA companies and the State’s investment environment, attracting strong interstate and global interest in the WA brand and its potential.

Looking ahead: AusMedtech 2026 in Perth

WA will host AusMedtech 2026, bringing the nation’s premier medical technology conference to Perth. This is a significant opportunity to further highlight WA’s thriving biotech and medtech ecosystem on the national stage.